
-
Latest Dermatology Research from JAAD (January 2025)
Explore the latest JAAD dermatology research on seborrheic dermatitis, vitiligo treatment, psoriasis biologics, melasma, pediatric warts, and squamous cell carcinoma therapies in this comprehensive review. -
Revolutionizing Dermatology: The Groundbreaking Release of China's First Reflectance Confocal Microscopy by Kernel Medical
Introducing the groundbreaking release of China's first-ever Reflectance Confocal Microscopy by Kernel Medical. This innovative device, the RCT-9503, offers unparalleled imaging capabilities for non-invasive skin diagnostics. Discover how this cutting-edge technology is revolutionizing dermatology and setting new standards in medical imaging. -
KernelMed to Showcase Innovative Products at 2025 AAD Annual Meeting in Orlando
KernelMed will showcase its innovative products at the 2025 AAD Annual Meeting in Orlando, Florida, from March 7-11. Visit Booth No. 2675 for solutions in phototherapy, skin care, and hair growth. -
Nature's Groundbreaking Discovery: Skin as the Body's Largest Immune Organ
Discover how the skin, our largest organ, functions as an autonomous immune organ, producing local antibodies to regulate microbiota and defend against infections. -
Melatonin: A Promising Treatment for Melasma? New Clinical Evidence Revealed 2024
Discover how oral melatonin may revolutionize melasma treatment. A recent clinical trial highlights its promising efficacy, providing proof-of-concept evidence for this antioxidant therapy. -
Recent Insights in Dermatology: A Review of 2024(January to June) Highlights
Stay updated with the latest dermatology research! This blog summarizes the highlights from the 2024 issues of JAMA Dermatology, JAAD, JEADV, and BJD, covering the latest treatments and findings for acne, vitiligo, psoriasis, atopic dermatitis, and more. Stay ahead with the latest dermatology knowledge! -
KernelMed Showcases Cutting-Edge Dermatology Solutions at MEDICA 2024
Join KernelMed at MEDICA 2024 from November 11-14 in Düsseldorf! Visit booth 15C12.8 to explore our UV phototherapy, LED photodynamic therapy, colposcope systems, and more. -
Low-level laser therapy for androgenetic alopecia
Low-level laser therapy for androgenetic alopecia has been used clinically for over ten years,with definite efficacy and high safety. A variety of low-level laser devices have been approved and marketed domestically,and are widely used in clinical settings,yet there are currently no unified usage standards. This consensus compiled and summarized relevant guidelines and clinical research from both domestic and international sources in recent years,providing a reference for the correct selection and use of low-level laser therapy for androgenetic alopecia in clinical practice. -
KernelMed and Philips celebrate their 20th anniversary of partnership
Explore the dynamic twenty-year collaboration between KernelMed and Philips, pioneers in the realm of phototherapy. Discover their shared journey of innovation, strategic insights, and mutual growth, shaping the future of medical technology. Delve into their celebration, industry insights, and vision for continued partnership in our latest blog. -
Empowering Healthcare: Kernel Medical Equipment Co., Ltd's Triumph at the 89th CMEF Exhibition
Elevate healthcare standards with Kernel Medical Equipment Co., Ltd.'s innovative devices showcased at the 89th CMEF Exhibition. Explore UV phototherapy, LED photodynamic therapy, diagnostic tools, and holistic treatment solutions. Engage with industry leaders in advancing patient care. -
3 Great Breakthrough in Vitiligo Treatment in the Wold Updated in January
Discover groundbreaking advancements in vitiligo treatment. FDA-approved ruxolitinib capsules show remarkable efficacy, with over half of adult patients experiencing significant improvement. Explore a new target, IL-33, identified by European scientists, offering potential treatment options. Chinese scientists make strides with gene therapy, a promising breakthrough in vitiligo treatment. Stay informed on the latest innovations. -
10 breaking news in vitiligo treatment in November 2023
Latest Breakthroughs in Vitiligo Research and Treatment (November 2023). Explore international expert recommendations on diagnosis and management, innovative therapies like topical ruxolitinib, and emerging insights into vitiligo pathogenesis. Discover new perspectives on Wnt/β-catenin signaling, systemic connections with lupus, and promising studies on topical tacrolimus and methotrexate efficacy. Stay ahead in vitiligo care with cutting-edge updates.
Get the latest price? We'll respond as soon as possible(within 12 hours)